Cassava Sciences

SAVA45

$26.91arrow_drop_up2.75%$0.71

SAVA45

$26.91

arrow_drop_up2.75%$0.71

Performance History

Key Stats
Open	$26.46
Prev. Close	$26.14
EPS	-1.42
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	25.50	28.88
52 Week Range	8.79	42.20

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-1.42

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Cassava Sciences (SAVA)

Cassava Sciences Inc (SAVA) is a biotechnology company that focuses on the development of novel drugs for the treatment of neurodegenerative diseases. The company's lead drug candidate, PTI-125, is being evaluated for its potential to treat Alzheimer's disease. Cassava Sciences Inc has a strong stock price history, with consistent growth over the past few years. The stock has a current market cap of $1.5 billion, making it a relatively small but promising player in the industry. In terms of financial performance, Cassava Sciences Inc has shown positive results, with a strong PEG ratio of 0.89. This indicates that the stock is undervalued compared to its expected earnings growth.

When comparing Cassava Sciences Inc to its industry peers, the company stands out for its innovative drug pipeline and potential for significant growth. The stock has outperformed the industry average, providing investors with solid returns. Cassava Sciences Inc has a 52-week range of $5.25 to $115.79, indicating its ability to generate substantial value for shareholders. The stock's day range is currently $84.50 to $92.10, showing a relatively stable trading pattern. In terms of trading volume, Cassava Sciences Inc has been quite active, with an average daily volume of 1.5 million shares.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Remi Barbier
Headquarters: Austin
Employees: 26
Exchange: NASDAQ

Keep an eye on Cassava Sciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Cassava Sciences 's (SAVA) price per share?

The current price per share for Cassava Sciences (SAVA) is $26.91. The stock has seen a price change of $0.72 recently, indicating a 2.75% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Cassava Sciences (SAVA)?

For Cassava Sciences (SAVA), the 52-week high is $42.2, which is 56.82% from the current price. The 52-week low is $8.79, the current price is 206.14% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Cassava Sciences (SAVA) a growth stock?

Cassava Sciences (SAVA) has shown an average price growth of -6.65% over the past three years. It has received a score of 23 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Cassava Sciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Cassava Sciences (SAVA) stock price performance year to date (YTD)?

As of the latest data, Cassava Sciences (SAVA) has a year-to-date price change of 20.03%. Over the past month, the stock has experienced a price change of -9.18%. Over the last three months, the change has been -5.61%. Over the past six months, the figure is 24.81%. Looking at a longer horizon, the five-year price change stands at 2.94K%.

help

Is Cassava Sciences (SAVA) a profitable company?

Cassava Sciences (SAVA) has a net income of -$97.22M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 100%, providing insight into the company's sales performance and growth. Operating income is noted at -$105.96M. Furthermore, the EBITDA is -$143.32M.

help

What is the market capitalization of Cassava Sciences (SAVA)?

Cassava Sciences (SAVA) has a market capitalization of $1.29B. The average daily trading volume is 27.72, indicating the stock's liquidity and investor engagement.